Richard Murray
Director/Board Member presso Stellular Bio, Inc.
Profilo
Richard Murray was the founder of EOS Biotechnology, Inc. founded in 1998 where he held the title of Vice President-Research until 2003.
He is currently a Director at Stellular Bio, Inc. since 2019.
Dr. Murray's former positions include Director, Chief Scientific Officer & EVP at PDL BioPharma, Inc. from 2007 to 2008, Director at Jounce Therapeutics, Inc. in 2023, Senior Vice President-Research & Development at Merck & Co., Inc. from 2009 to 2014, Chief Scientific & Technical Officer & Senior VP at Protein Design Labs, Inc. from 2003 to 2006, and Senior Staff Scientist at DNAX Research, Inc. from 1991 to 1998.
Dr. Murray's education includes an undergraduate degree from the University of Massachusetts, and doctorate degrees from The University of North Carolina at Chapel Hill and The University of North Carolina at Charlotte.
Posizioni attive di Richard Murray
| Società | Posizione | Inizio |
|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Director/Board Member | 04/06/2019 |
Precedenti posizioni note di Richard Murray
| Società | Posizione | Fine |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Chief Executive Officer | 31/03/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2014 |
| PDL BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 05/09/2008 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Chief Tech/Sci/R&D Officer | 10/01/2006 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Founder | 01/04/2003 |
Formazione di Richard Murray
| University of Massachusetts | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
| DNAX Research, Inc. | |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Borsa valori
- Insiders
- Richard Murray
